KUALA LUMPUR, Dec 16 — Sanofi and AstraZeneca’s Beyfortus (Nirsevimab) is now approved by the National Pharmaceutical ...
We recently compiled a list of 9 Most Undervalued Pharma Stocks to Buy Right Now. Sanofi is among the most undervalued stocks ...
Federal regulators have begun a safety review of two RSV medicines used to protect infants, even though no safety problems ...
Northwell Health reports pediatricians emphasize vaccines' effectiveness and safety, urging parents to follow the recommended ...
Federal regulators have begun a safety review of 2 RSV medicines used to protect infants, even though no safety problems have been reported.
On the campaign trail last October, President Trump promised to let his health secretary, Robert F. Kennedy Jr., “go wild on ...
Discusses Year-End Late-Stage Pipeline Review With Focus on Clinical and Regulatory Developments December 16, 2025 11:15 AM ...
Sanofi sees continued growth and strong financials despite a pipeline setback. Click for this updated look at SNY stock ...
“FDA is doing a thorough investigation, across multiple age groups, of deaths potentially related to coronavirus vaccines,” said Andrew Nixon, spokesperson for the U.S. Department of Health and Human ...
Everyday Health on MSN

RSV vaccine: What you need to know

Learn about this vaccine that protects against a common seasonal virus that can sometimes cause severe disease, with info on ...
U.S. regulators launch new review of infant RSV therapies from Merck, Sanofi, and AstraZeneca amid scrutiny by Health Secretary Robert F. Kennedy Jr.